In a PM Live guest blog this
month, Dovetail’s Director, Claire Munro argues that for companies to survive
the raft of major changes affecting pharma, they need to get better at joint
working. She explores the demographic, scientific and technological changes that
are causing tectonic shifts in the industry, and suggests that collaboration is
one of the key skills companies will need to develop, in order to successfully navigate
the evolving environment.
While technological advances like
the fast developing fields of real-world data and artificial intelligence have
great potential to positively impact healthcare systems, other changes such as
an ageing population and the rising prevalence of obesity and dementia are increasing
the pressures on health services.
Working in partnership with
clinicians and policy makers, pharma companies have the chance to harness
developments and become part of the solution. But Claire cautions against
rushing into collaboration without understanding the importance of good process,
and points out the value of independent third parties that are able to help bridge
the gap between companies and their stakeholders.
Award-winning healthcare collaboration specialists Dovetail will this month pilot a new programme of workshops on improving joint working between industry and clinicians for the benefit of patients. The first meeting will bring together a diverse group of experts from a range of clinical specialities and industry roles, each with a strong track record in collaboration. claire@dovetailstrategies.com
Dovetail Director Claire Munro on effective leadership strategies that drive results in joint working between pharma and clinical groups. claire@dovetailstrategies.com